Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+36.5K
-
Total reported value, excl. options
-
$16.4M
-
Value change
-
+$44.2K
-
Put/Call ratio
-
0
-
Number of buys
-
12
-
Number of sells
-
-21
-
Price
-
$1.46
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q3 2023
61 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q3 2023.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 79.8M outstanding shares and own 14.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.04M shares), Tieton Capital Management, LLC (2.45M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (908K shares), GEODE CAPITAL MANAGEMENT, LLC (504K shares), RENAISSANCE TECHNOLOGIES LLC (445K shares), GMT CAPITAL CORP (297K shares), GAMCO INVESTORS, INC. ET AL (260K shares), MILLENNIUM MANAGEMENT LLC (231K shares), and STATE STREET CORP (190K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.